Fmoc-Dab(Fmoc)-OH, also known as Fmoc-diaminobutyric acid, is a protected amino acid commonly used in peptide synthesis. The "Fmoc" (9-fluorenylmethoxycarbonyl) group serves as a protective group for the amino functionality, allowing for selective reactions during peptide assembly. This compound features a diamine structure, with two amine groups separated by a butyric acid chain, which contributes to its unique properties in peptide chemistry. The presence of the Fmoc group enhances the stability of the amino acid during synthesis and facilitates its removal under mild basic conditions, making it advantageous for sequential coupling reactions. Fmoc-Dab(Fmoc)-OH is typically utilized in solid-phase peptide synthesis (SPPS) and can influence the conformation and solubility of the resulting peptides. Its CAS number, 201473-83-8, allows for easy identification in chemical databases. Overall, this compound is significant in the field of biochemistry and pharmaceutical development, particularly in the design of peptide-based therapeutics.

Fmoc-Dab(Fmoc)-OH

201473-83-8: Fmoc-Dab(Fmoc)-OH, also known as Fmoc-diaminobutyric acid, is a protected amino acid commonly used in peptide synthesis. The "Fmoc" (9-fluorenylmethoxycarbonyl) group serves as a protective group for the amino functionality, allowing for selective reactions during peptide assembly. This compound features a diamine structure, with two amine groups separated by a butyric acid chain, which contributes to its unique properties in peptide chemistry. The presence of the Fmoc group enhances the stability of the amino acid during synthesis and facilitates its removal under mild basic conditions, making it advantageous for sequential coupling reactions. Fmoc-Dab(Fmoc)-OH is typically utilized in solid-phase peptide synthesis (SPPS) and can influence the conformation and solubility of the resulting peptides. Its CAS number, 201473-83-8, allows for easy identification in chemical databases. Overall, this compound is significant in the field of biochemistry and pharmaceutical development, particularly in the design of peptide-based therapeutics.

Butanoic acid, 2,4-bis[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-

<p>(S)-2,4-Bis(Fmoc-Amino)Butyric Acid</p>

CAS 201473-83-8

Fmoc-Dab(Fmoc)-OH

Butanoic acid, 2,4-bis[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-

Ref: IN-DA002DG1

(S)-2,4-Bis(Fmoc-Amino)Butyric Acid

Ref: 54-OR1008663

Butanoic acid, 2,4-bis[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, (2S)-

Ref: 10-F862180